MENU
+Compare
PASG
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$0.67
Change
+$0.02 (+3.08%)
Capitalization
40.77M

PASG Passage Bio Forecast, Technical & Fundamental Analysis

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PASG with price predictions
Dec 19, 2024

PASG's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for PASG moved out of overbought territory on December 02, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 instances where the indicator moved out of the overbought zone. In of the 14 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 13, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PASG as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PASG turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

PASG moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PASG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PASG broke above its upper Bollinger Band on November 29, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for PASG crossed bullishly above the 50-day moving average on December 02, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PASG advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 119 cases where PASG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.561) is normal, around the industry mean (14.373). P/E Ratio (0.000) is within average values for comparable stocks, (86.966). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.752). PASG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (252.663).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PASG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PASG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PASG is expected to report earnings to fall 27.10% to -22 cents per share on February 27

Passage Bio PASG Stock Earnings Reports
Q4'24
Est.
$-0.23
Q3'24
Missed
by $0.08
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.09
The last earnings report on November 13 showed earnings per share of -31 cents, missing the estimate of -23 cents. With 3.17M shares outstanding, the current market capitalization sits at 40.77M.
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CREX2.850.08
+2.70%
Creative Realities
RIGL17.210.14
+0.82%
Rigel Pharmaceuticals Inc
OKE97.660.02
+0.02%
Oneok
RDN31.73N/A
N/A
Radian Group
SBH11.86-0.26
-2.15%
Sally Beauty Holdings

PASG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
+6.95%
AXON - PASG
43%
Loosely correlated
+0.94%
CYTK - PASG
38%
Loosely correlated
+0.82%
ARRY - PASG
35%
Loosely correlated
-0.74%
SNPX - PASG
32%
Poorly correlated
-0.19%
CABA - PASG
31%
Poorly correlated
+0.87%
More